We are live on
!
Find out more
CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.67B
1-Year Est. Return
89%
This Fund
S&P 500
This Quarter
Est. Return
-1.39%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$345M
AUM Growth
+$21M
(+6.5%)
Cap. Flow
+$33.8M
Cap. Flow
% of AUM
9.8%
Top 10 Holdings %
Top 10 Hldgs %
32.78%
Holding
466
New
14
Increased
365
Reduced
39
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$4.2M |
| 2 |
Procter & Gamble
PG
|
+$3.18M |
| 3 |
Apple
AAPL
|
+$2.96M |
| 4 |
Booking.com
BKNG
|
+$2.81M |
| 5 |
Diageo
DEO
|
+$2.76M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$3.37M |
| 2 |
NVIDIA
NVDA
|
+$3.35M |
| 3 |
On Holding
ONON
|
+$2.92M |
| 4 |
Carnival Corporation Ltd
CCL
|
+$2.64M |
| 5 |
ASML
ASML
|
+$2.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.24% |
| 2 | Consumer Discretionary | 20.57% |
| 3 | Healthcare | 19.52% |
| 4 | Communication Services | 8.19% |
| 5 | Consumer Staples | 3.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Sana Biotechnology
SANA
$1.13B
| $19.5K | 0.01% |
5,047
+2,537
| +101% | +$13.6K |
|
302
Regenxbio
RGNX
$720M
| $18.5K | 0.01% |
1,125
+555
| +97% | +$10.1K |
|
303
Repligen
RGEN
$9.35B
| $18.3K | 0.01% |
115
| – | – |
|
304
Edwards Lifesciences
EW
$53.6B
| $17.7K | 0.01% |
256
| – | – |
|
305
Novavax
NVAX
$1.31B
| $17.6K | 0.01% |
2,424
+1,293
| +114% | +$10.3K |
|
306
Arcturus Therapeutics
ARCT
$216M
| $17.5K | 0.01% |
683
+335
| +96% | +$10.3K |
|
307
Charles River Laboratories
CRL
$13.6B
| $17.4K | 0.01% |
89
| – | – |
|
308
Kura Oncology
KURA
$882M
| $17.3K | 0.01% |
1,898
+1,001
| +112% | +$10.2K |
|
309
Travere Therapeutics
TVTX
$5.86B
| $17.1K | 0.01% |
1,917
+939
| +96% | +$13.3K |
|
|
LKFT
310
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.83B
| $17.1K | 0.01% |
495
+265
| +115% | +$10.3K |
|
311
IQVIA
IQV
$39.8B
| $16.5K | ﹤0.01% |
84
| – | – |
|
312
Editas Medicine
EDIT
$436M
| $16.3K | ﹤0.01% |
2,095
+1,190
| +131% | +$10.2K |
|
|
FTCH
313
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $16.3K | ﹤0.01% |
7,800
| – | – |
|
314
Kiniksa Pharmaceuticals
KNSA
$6.1B
| $15.8K | ﹤0.01% |
911
+453
| +99% | +$7.63K |
|
315
Phathom Pharmaceuticals
PHAT
$742M
| $15.1K | ﹤0.01% |
1,455
+738
| +103% | +$10.1K |
|
|
RAPT
316
DELISTED
RAPT Therapeutics
RAPT
| $14.8K | ﹤0.01% |
111
+55
| +98% | +$8.98K |
|
|
EXAS
317
DELISTED
Exact Sciences
EXAS
| $14.7K | ﹤0.01% |
216
-6,941
| -97% | -$589K |
|
|
PETQ
318
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $14.7K | ﹤0.01% |
747
+365
| +96% | +$6.53K |
|
319
Tarsus Pharmaceuticals
TARS
$3.07B
| $14.7K | ﹤0.01% |
828
+476
| +135% | +$8.42K |
|
320
Wave Life Sciences
WVE
$1.03B
| $14.6K | ﹤0.01% |
2,536
+1,247
| +97% | +$5.69K |
|
|
ALPN
321
DELISTED
Alpine Immune Sciences Inc
ALPN
| $14.5K | ﹤0.01% |
1,269
+640
| +102% | +$7.88K |
|
322
Dyne Therapeutics
DYN
$4.89B
| $14K | ﹤0.01% |
1,558
+794
| +104% | +$8.55K |
|
323
Alector
ALEC
$240M
| $13.9K | ﹤0.01% |
2,149
+1,056
| +97% | +$6.84K |
|
324
Anavex Life Sciences
AVXL
$316M
| $13.8K | ﹤0.01% |
2,103
+1,044
| +99% | +$8.31K |
|
325
4D Molecular Therapeutics
FDMT
$621M
| $13.7K | ﹤0.01% |
1,078
+529
| +96% | +$8.85K |
|
Similar funds
HA
JPM
CPO
LCI
GWM
JIP
RMC
GACM
China Universal Asset Management Company's Q3 2023 Portfolio in Review
As of Q3 2023, China Universal Asset Management Company held 466 positions worth $345M, up 6.5% from $324M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
China Universal Asset Management Company deployed $33.8M of net new capital in Q3 2023, opening 14 new positions and adding to 365 existing holdings. Its largest new stake was SPDR Gold MiniShares Trust: 71,700 shares worth $2.63M.
By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 42% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was TSMC, an estimated $3.37M trimmed.
- China Universal Asset Management Company's largest Q3 2023 buy was SPDR Gold MiniShares Trust: 71,700 shares worth $2.63M.
- China Universal Asset Management Company added most to Amazon in Q3 2023, an estimated $4.2M increase.
- China Universal Asset Management Company's biggest Q3 2023 reduction was TSMC, cutting an estimated $3.37M.
- China Universal Asset Management Company fully exited Carnival Corporation Ltd in Q3 2023, selling an estimated $2.64M.
- China Universal Asset Management Company's ten largest holdings make up 33% of its $345M portfolio in Q3 2023.
- China Universal Asset Management Company opened 14 new positions and closed 20 in Q3 2023.
- China Universal Asset Management Company's portfolio value rose 6.5% quarter-over-quarter to $345M.
Based on China Universal Asset Management Company's 13F filing for Q3 2023, filed 31 Oct 2023.